For instance, in one 1960s study of intravenous NAD+ for addiction, patients who received a fast IV drip experienced immediate headache and shortness of breath, whereas those given the same dose at a slower drip rate (under approximately 35 drops/min) had no distress
doi: 10.1016/j.cmet.2016.05.011 61 SalminenAKaarnirantaK
PubMed , Cellular & Molecular Immunology , vol
The maintenance phase typically occurs once you reach your target dose, usually between 10 and 15 milligrams weekly
This highlights the need for further research to distinguish between the risk of developing an autoimmune phenotype and the risk of progressing to severe clinical manifestations like TED. While the research teams findings suggest a protective association between GLP-1 drug therapy and TED, the underlying biological pathways remain speculative
Price DA, Deng Q, Kipnes M, Beck SE